Ireland – Financial management consultancy services – Dynamic Purchasing System (DPS) for Consultancy Services to Atlantic Technological University (ATU)
ted.europa.eu
Buyer: Atlantic Technological University | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2028-11-02
TenderProcurement ContractIrelandOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 2, 2028
Buyer: Atlantic Technological University | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2028-11-02
GRA
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
grants.gov
This Notice of Funding Opportunity (NOFO) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-si...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 2, 2028
This Notice of Funding Opportunity (NOFO) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO (PAR-27-012) for a collaborating Clinical Coordinating Center (CCC). The obj...
GRA
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
grants.gov
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 2, 2028
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies.Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with...
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including ef...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 2, 2028
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies. Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven mechanism of award. The objective of the application is to present the scientific rationale for the clinic...
TEN
France – Engineering design services for mechanical and electrical installations for buildings – Système d'acquisition dynamique - Missions d'études en électricité (CFO-CFA)
Slovakia – Engineering services – DNS - Inžinierska činnosť
ted.europa.eu
Buyer: Hlavné mesto Slovenskej republiky Bratislava | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-03
TenderProcurement ContractSlovakiaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2028
Buyer: Hlavné mesto Slovenskej republiky Bratislava | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-03
TEN
Denmark – Engineering services – Dynamisk indkøbssystem for indkøb af ressourcepersoner - kategori 2 - byggeledelse
ted.europa.eu
Buyer: Københavns Kommune - Teknik- og Miljøforvaltningen | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-...
TenderProcurement ContractDenmarkOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2028
Buyer: Københavns Kommune - Teknik- og Miljøforvaltningen | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-03
TEN
Denmark – Engineering services – Dynamisk indkøbssystem for indkøb af ressourcepersoner - kategori 1 - projektledelse
ted.europa.eu
Buyer: Københavns Kommune - Teknik- og Miljøforvaltningen | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-...
TenderProcurement ContractDenmarkOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2028
Buyer: Københavns Kommune - Teknik- og Miljøforvaltningen | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-11-03
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guanfacin, ATC N06BA21 für die Zeit 01.01.2026 - 31.12.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pazopanib, ATC L01EX03 für die Zeit 01.01.2026 - 31.12.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $400,000
DeadlineNov 5, 2028
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
GRA
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit basic research applications to investigate the pathological mechanisms of skin...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $300,000
DeadlineNov 5, 2028
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit basic research applications to investigate the pathological mechanisms of skin injuries caused by toxic Chemicals of Concern (CoC) identified as public health threats by the United States Government. This NOFO supports the goal of the trans-NIH Chemical Countermeasures Research Program (CCRP) and is intended to spur the discovery and early development of broad-spectrum medical countermeasures (MCMs) to advance the nation's medical and public health preparedness for, response to, and recovery from high consequence chemical disasters and emergencies.
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
Norway – Transport services (excl. Waste transport) – Dynamic purchasing system for the procurement of job fruit for Oslo municipalityBuyer: Oslo kommune v/ Utviklings- og kompetanseetaten | Notice type: cn-standard | Procedure: restricted | Contract: services | D...
Tender
Procurement Contract
Norway
Not provided on the source page. Please check the official source.
Lithuania – Health and safety consultancy services – DPS Statinio statybos saugos ir sveikatos koordinatoriaus paslaugosBuyer: Uždaroji akcinė bendrovė „Vilniaus vystymo kompanija“ (PV) | Notice type: cn-standard | Procedure: restricted | Contract: s...
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
Buyer: Atlantic Technological University | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2028-11-02
42262
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)This Notice of Funding Opportunity (NOFO) supports applications for a collaborating Data Coordinating Center (DCC) for investigato...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This Notice of Funding Opportunity (NOFO) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO (PAR-27-012) for a collaborating Clinical Coordinating Center (CCC). The objective of the DCC application is to present a comprehensive plan to provide overall project coordination, administration, data management, and biostatistical support for the clinical trial proposed in the collaborating CCC application. The application should also describe its approaches to collaborate with the CCC on implementation of the clinical trial community engagement plan. Both a DCC application and a collaborating CCC application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Resear...
42263
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for in...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies.Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO for a collaborating Data Coordinating Center (PAR-27-013). The objective of the CCC application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The application should also describe its approaches to increasing community engagement from conceptual design of the intervention through implementation and sustainability and close...
42264
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies. Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven mechanism of award. The objective of the application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, participant recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The multiple PD/PI model is strongly encouraged but not required. Applicants are encouraged to include a PD/PI with expertise in biostatistics, clinical trial design, and coordination. The application should also describe its approaches to increase community engagement from conceptual design of the intervention through implementation and sus...
42265
France – Engineering design services for mechanical and electrical installations for buildings – Système d'acquisition dynamique - Missions d'études en électricité (CFO-CFA)Buyer: Sénat | Notice type: cn-standard | Procedure: oth-mult | Contract: services | Deadline: 2028-11-03
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Slovakia – Engineering services – DNS - Inžinierska činnosťBuyer: Hlavné mesto Slovenskej republiky Bratislava | Notice type: cn-standard | Procedure: restricted | Contract: services | Dead...
Tender
Procurement Contract
Slovakia
Not provided on the source page. Please check the official source.
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in uter...
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
42275
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)The purpose of this Notice of Funding Opportunity (NOFO) is to solicit basic research applications to investigate the pathological...
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit basic research applications to investigate the pathological mechanisms of skin injuries caused by toxic Chemicals of Concern (CoC) identified as public health threats by the United States Government. This NOFO supports the goal of the trans-NIH Chemical Countermeasures Research Program (CCRP) and is intended to spur the discovery and early development of broad-spectrum medical countermeasures (MCMs) to advance the nation's medical and public health preparedness for, response to, and recovery from high consequence chemical disasters and emergencies.
No saved opportunities on this page. Use the star icon near an opportunity title.
